These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 8102517

  • 1. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
    Lipponen HJ, Aaltomaa S, Syrjänen S, Syrjänen K.
    Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
    [Abstract] [Full Text] [Related]

  • 2. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer.
    Lipponen P, Saarelainen E, Ji H, Aaltomaa S, Syrjänen K.
    J Pathol; 1994 Oct; 174(2):101-9. PubMed ID: 7965405
    [Abstract] [Full Text] [Related]

  • 3. Expression of p53 protein has no independent prognostic value in breast cancer.
    Pietiläinen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma VM, Syrjänen K.
    J Pathol; 1995 Nov; 177(3):225-32. PubMed ID: 8551383
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of immunohistochemical c-erbB-2 proto-oncogene expression and nuclear DNA content in human breast cancer.
    Schimmelpenning H, Eriksson ET, Falkmer UG, Rutqvist LE, Johansson H, Fallenius A, Auer GU.
    Eur J Surg Oncol; 1992 Dec; 18(6):530-7. PubMed ID: 1362164
    [Abstract] [Full Text] [Related]

  • 5. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S, Khalifa A, el-Gharib A, Salah N, Mohamed MK.
    Anticancer Res; 1997 Dec; 17(2B):1417-23. PubMed ID: 9137508
    [Abstract] [Full Text] [Related]

  • 6. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
    Rudolph P, Olsson H, Bonatz G, Ratjen V, Bolte H, Baldetorp B, Fernö M, Parwaresch R, Alm P.
    J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer.
    Nakopoulou LL, Alexiadou A, Theodoropoulos GE, Lazaris AC, Tzonou A, Keramopoulos A.
    J Pathol; 1996 May; 179(1):31-8. PubMed ID: 8691341
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH, Dervan PA, O'Regan M, Codd MB, Gullick WJ, Tobin BM, Carney DN.
    Cancer Res; 1991 Jun 15; 51(12):3296-303. PubMed ID: 1674898
    [Abstract] [Full Text] [Related]

  • 9. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC, Dietrich KD, Danyluk J, Paterson AH, Lees AW, Jamil N, Hanson J, Jenkins H, Krause BE, McBlain WA.
    Cancer Res; 1991 Jan 15; 51(2):556-67. PubMed ID: 1670762
    [Abstract] [Full Text] [Related]

  • 10. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer.
    Eissa S, Khalifa A, el-Gharib A, Salah N, Mohamed MK.
    Anticancer Res; 1997 Jan 15; 17(4B):3091-7. PubMed ID: 9329609
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 12. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
    Giatromanolaki A, Koukourakis MI, Sivridis E, Fountzilas G.
    Anticancer Res; 2000 Apr 12; 20(2A):997-1004. PubMed ID: 10810387
    [Abstract] [Full Text] [Related]

  • 13. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
    el-Ahmady O, el-Salahy E, Mahmoud M, Wahab MA, Eissa S, Khalifa A.
    Anticancer Res; 2002 Apr 12; 22(4):2493-9. PubMed ID: 12174951
    [Abstract] [Full Text] [Related]

  • 14. Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer.
    Horak E, Smith K, Bromley L, LeJeune S, Greenall M, Lane D, Harris AL.
    Oncogene; 1991 Dec 12; 6(12):2277-84. PubMed ID: 1685017
    [Abstract] [Full Text] [Related]

  • 15. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
    Baak JP, Chin D, van Diest PJ, Ortiz R, Matze-Cok P, Bacus SS.
    Lab Invest; 1991 Feb 12; 64(2):215-23. PubMed ID: 1671789
    [Abstract] [Full Text] [Related]

  • 16. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May 12; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 17. Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival.
    Pietiläinen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma VM, Syrjänen K.
    Anticancer Res; 1995 May 12; 15(3):959-64. PubMed ID: 7645986
    [Abstract] [Full Text] [Related]

  • 18. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.
    Logullo AF, Lopes AB, Nonogaki S, Soares FA, Netto MM, Nishimoto IN, Brentani MM.
    Oncol Rep; 2007 Jul 12; 18(1):121-6. PubMed ID: 17549356
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C, Wejaranayang C, Vipupinyo C.
    J Med Assoc Thai; 2008 Dec 12; 91(12):1779-84. PubMed ID: 19133508
    [Abstract] [Full Text] [Related]

  • 20. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL.
    APMIS Suppl; 2003 Dec 12; (108):1-67. PubMed ID: 12874968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.